Upload
nathan-mckinney
View
216
Download
0
Embed Size (px)
Citation preview
FasL: a double-edged sword for tumor formation
Differential effects of FasL on tumor formation Cell-cell contact suppresses Fas-mediated
apoptosis Unconventional Fas signal for gene expression FasL reverse signaling
楊倍昌國立成功大學醫學院微生物及免疫學研究所
BC Yang
Fight cancer, But, sometimes we lose
BC Yang
The great escape: Resistance to killing
• Defective Fas pathway• Resistance to Granzyme
• Fas-L and Neutrophil
Cytotoxic T cells
Innate immunity
BC Yang
Immune privilege or inflammation? Joe O'Connell et al. Nature Medicine 7, 271 - 274 (2001)
BC Yang
Caspase 3 Apaf-1Caspase 9Death substrates
Apoptosis
Nature 407, 789 – 795(2000)
Nagata, S. (Fas); Krammer, P. (Apo1)
CD95/CD95-L
Transducing death signal
Involving in cytotoxicity, immune homeostasis, tumor formation, etc.
BC Yang
In vivo consequences of FasL expression by tumors
(using over-expression system)
Enhanced rejection Delayed rejection
Renca, MH134, L5178Y, B16/BL6, CT26*
Note: *:syngenic, nude, SCID #: allogenic, lpr
Ref: Lejeune FJ et al., 1998, Curr. Op. Immunol.
CT26#
B16-F10
BC Yang
FasLribozyme/EGFP plasmid
Hammerhead ribozyme.
54-mers. Inserted into the
pEGFP-N1. Driven by CMV
promoter.
Chio CC, Wang YS, Chen YL, Lin SJ and Yang BC (2001) Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumor infiltrating cells, and liver damage but accelerates tumor formation in nude mice.
Br J Cancer 85:1185-1192
BC Yang
U-373MG cells transfected withFasLribozyme/EGFP plasmid
Light microscopy
Fluorescent microscopy Immunohistochemistry (tumor cells in tissue)
-tubulinFas-ligand
U37
3(v)
U37
3(R
)U
118(
v)U
118(
R)
BC Yang
Tumor formation in nude mice
FasLhigh
FasLlow
Br J Cancer (2001) 85, 1185
• Tumor cells
• T, B, Macrophages, monocytes, granulocytes, etc….
• Stroma cells
• Blood vessels
BC Yang
Q: How about the action of tumor FasL in immune intact mice?
A: It is organ dependent!
BC Yang
Animal model
C57B/6 Melanoma cell line
B6F10 Gene knockdown by
FasL ribozyme Subcutis/lung
BC Yang
Effect of FasL on growth and death of B16F10 cells
Apoptosis in 3-day cultureCell growth rate
BC Yang
Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behavior (B16F10 in C57BL/6)
Br J Cancer, 87: 359 (2002)
BC Yang
Depletion of CD4, CD8 T cells and PMNs affected lung metastasis
4410
41 357 95154
Vector controls Fas-Lribozyme
What happened here?Br J Cancer, 87: 359 (2002)
BC Yang
Control
Fas-Lribozyme
In subcutaneous environment: FasL on tumor cells mediates inactivation of neutrophils
5x105cells subcutaneous injection
FasL on tumor cells mediates inactivation of neutrophils. J. Immunol. (2003) 171:1183-1192
BC Yang
Vector controls Fas-L-ribozyme
Depletion of CD4, CD8 T cells and PMNs affected subcutaneous tumor formation
BC Yang
Tumor FasLhigh impairs neutrophil activation: gelatinase B, ROS, CD-11b, and FasL (In coculture for 24 h).
Cell death
Gelatinase B ROS
J. Immunol. (2003) 171:1183-1192
BC Yang
Puzzles on tissue specificity (to be answered)
Factors responsible for tissue specificity
Function of immune cells in different tissues
BC Yang
No death occurred in Jurkat cells during coculture with gliomas
PI-staining
A B
C D E
A: Jurkat cells alone
B: CH-11 (1ng/ml)
C: with U-118MG(V)
D: with U118MG (R)
E: ZB4 (100ng/ml)/CH-11
免疫細胞沒那麼容易死亡 :
BC Yang
Coculture with tumor cells inhibits the Fas-mediated apoptosis.
Can ECM play a role in this protection?
0.0
10.0
20.0
30.0
40.0
50.0
60.0
J CH-11 U118V U118V+CH-11
U118R U118R+CH-11
HeLa HeLa+CH-11
Huh-7 Huh-7 +CH-11
A549 A549 +CH-11
Apo
ptos
is (%
)
24 h 48 h
BC Yang
BC Yang
Death pathway inhibited
DISC formation reduced
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
mediumCH-11
U118(V)
U118(V)+CH-11
U118(R)
U118(R)+CH-11
U118(V)+CH-11 (upper)
U118(V)+CH-11 (lower)
U118(R)+CH-11 (upper)
U118(R)+CH-11 (lower)
% A
po
pto
sis
U 118(V/R)
Jurkat cells
BC Yang
Cell-cell contact is required and integrins involved.
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
medium U118(V) CH-11 None blocking anti-β1
blocking anti-β2
blocking anti-β1+β2
% A
nnex
in V
-pos
itive
cel
ls
c
Coculture with glioma cells/conditioned media did not reduced the surface Fas protein.
BC Yang
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
None PD98059 U0126 SP600125 SB202190 GF190203X H-89 LY294002
% A
po
pto
sis
JJ+U118J+CH-11J+U118+CH-11
BC Yang
Intracellular signaling induced by cell-cell contact:PI3K/AKT is important for suppression of Fas-mediated apoptosis in T cells
BC Yang
Other anti-apoptosis genes
J Immunol. 2007, in revision
BC Yang
Phosphatidylinositol 3-Kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells
Fas/FasL interaction may create an immunosuppresive environment
• Induction of IL-10 in T cell lines upon contact with human glioma cells, that is mediated by Fas signaling through a PKA-independent pathway.
J Immunol (2003) 171:3947-3954.
BC Yang
Jurkat Molt-4 1 2 3 1 2 3 IL-10
-actin
Glioma-associated IL-10 induction in T cell lines
BC Yang
1. control, Jurkat alone2. Jurkat + U118MG3. Jurkat + U373MG
U373(V/R) or U118(V/R)
Jurkat cells 1 2 3 4
IL-10
-actin
Direct cell-to-cell contact is required
1. Jurkat alone2. Jurkat separate chamber3. Jurkat in upper chamber /coculture in low chamber4. Jurkat in coculture
U118(V)
BC Yang
Fas/Fas-L signal-associated IL-10 induction
Jurkat U-373MG U-118MG - V R V R IL-10 -actin
Molt-4 U-373MG U-118MG - V R V R IL-10
-actin
BC Yang
Fas
FasL
T cellsTumor
Tissue environment ?
Cytokines ? IL-10, IL-6, IL-8
Neutrophils
To help or not to help ?
To be solved
BC Yang
FasL reverse signaling
Suzuki I. and Fink PJ.. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med., 187:123, 1998.
Boursalian TE, Fink PJ, Mutation in Fas Ligand Impairs Maturation of Thymocytes Bearing Moderate Affinity T Cell Receptors, J. Exp. Med., 198, 349, 2003
Sun M, Ames KT, Suzuki I,. Fink PJ, The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals, J.Immunol., 177, 1481, 2006
BC Yang
3T3-N1 3T3-FasL 3T3-△33 3T3-Fas3T3-△70
FasL on lung metastases
Manuscript in preparation; 2007
BC Yang